Rare diseases
Investigational molecules
Locations
Oberduerrbacher Strasse 6, Grombuehl, 97080 Wuerzburg, Germany
Universitaetsklinikum Wuerzburg AöR in Wuerzburg, Germany specialises in clinical trials of conditions such as Plasma cell myeloma, Non-small cell lung cancer, Hidradenitis, Cardiac amyloidosis, and other specialisations. This site conducts important research.
The Neurological Clinic and Polyclinic at Universitaetsklinikum Wuerzburg AöR is conducting clinical research in the area of cardiovascular diseases, with a strong focus on acute ischemic stroke and high-risk transient ischemic attack. These studies are designed to better understand how to reduce the chance of another stroke and improve care for people at elevated risk.
This research reflects a focused effort to improve stroke prevention and treatment effectiveness in a major academic hospital setting in Wuerzburg.
Clinical trials currently enrolling participants at this site.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GermanyRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
GermanyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
GermanyA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
GermanyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
GermanyA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
GermanyA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
GermanyA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
GermanyA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
